Literature DB >> 28890192

Workplace availability, risk group and perceived barriers predictive of 2016-17 influenza vaccine uptake in the United States: A cross-sectional study.

Paula M Luz1, Riley E Johnson2, Heidi E Brown2.   

Abstract

BACKGROUND: Seasonal influenza, though mostly self-limited in the healthy adult, may lead to severe disease and/or complications in subpopulations. Annual influenza vaccination is available in many countries with coverage goals rarely being met. We conducted a cross-sectional study of influenza vaccine uptake and explored socio-demographic, economic, and psychological factors that explained vaccine uptake.
METHODS: The survey was administered via Amazon Mechanical Turk (MTurk) to United States residents in January 2017, using the Qualtrics platform. Using principal axis factor analysis, we reduced the 25 items theory-based psychological determinants into the primary constructs they measure if/when internal consistency was sufficient (Cronbach's alpha >0.60). Logistic regression models were used to quantify the association of socio-demographic, economic, and psychological factors with reported vaccine behavior in the 2016-17 flu season.
RESULTS: 1007 participants completed the survey, sex distribution was even, 67% had 25-44years of age, and 61% annual household income of $30-99 thousand United States dollars. About 25% had the flu shot offered at their workplace and 20% reported belonging to a group for whom the flu shot is recommended. Vaccine uptake was 31.5%. Eight predictors remained in the final adjusted model (R2=0.489), having the vaccine offered at the workplace, belonging to a group for whom the vaccine is recommended, and higher perceived barriers were the strongest predictors of vaccine uptake, increasing (and decreasing in the case of barriers) the odds by >3-fold. Additionally, higher household income, higher perceived susceptibility and higher perceived benefits also independently predicted vaccine uptake. DISCUSSION: We found evidence that perceived barriers significantly impaired vaccine uptake to the same extent that having the vaccine offered at the workplace or belonging to a group for whom the vaccine is recommended facilitated uptake. Ideally, a better understanding of drivers of vaccine hesitancy will result in improved interventions to increase vaccine uptake.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health attitude; Influenza; Vaccine hesitancy

Mesh:

Substances:

Year:  2017        PMID: 28890192     DOI: 10.1016/j.vaccine.2017.08.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  COVID-19 vaccination coverage by company size and the effects of workplace vaccination program in Japan: a cohort study.

Authors:  Koji Mori; Takahiro Mori; Tomohisa Nagata; Hajime Ando; Ayako Hino; Seiichiro Tateishi; Mayumi Tsuji; Keiji Muramatsu; Yoshihisa Fujino
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

2.  Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.

Authors:  Jennifer E Isenor; Beth A O'Reilly; Susan K Bowles
Journal:  BMC Public Health       Date:  2018-06-26       Impact factor: 3.295

3.  Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy.

Authors:  Gaia Bertoldo; Annalisa Pesce; Angela Pepe; Concetta Paola Pelullo; Gabriella Di Giuseppe
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

4.  Disgust as an emotional driver of vaccine attitudes and uptake? A mediation analysis.

Authors:  P M Luz; H E Brown; C J Struchiner
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

5.  Knowledge, Attitudes and Practices of Flu Vaccination in Hemodialysis Patients.

Authors:  Ada Gawryś; Tomasz Gołębiowski; Dorota Zielińska; Hanna Augustyniak-Bartosik; Magdalena Kuriata-Kordek; Leszek Szenborn; Magdalena Krajewska
Journal:  Vaccines (Basel)       Date:  2021-01-22

Review 6.  Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States.

Authors:  Yanjie Zhang; Rebecca J Fisk
Journal:  Glob Health J       Date:  2021-02-09

7.  The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.

Authors:  Nee Nee Chan; Khang Wei Ong; Ching Sin Siau; Kai Wei Lee; Suat Cheng Peh; Shakila Yacob; Yook Chin Chia; Vei Ken Seow; Pei Boon Ooi
Journal:  BMC Public Health       Date:  2022-02-14       Impact factor: 3.295

8.  Lowering the recommended age for the free and active offer of influenza vaccination in Italy: clinical and economic impact analysis in the Liguria region.

Authors:  Cecilia Trucchi; Marco D'Amelio; Daniela Amicizia; Andrea Orsi; Idalba Loiacono; Roberta Tosatto; Maria Francesca Piazza; Chiara Paganino; Andrea Pitrelli; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

9.  Exploring the Willingness to Accept SARS-CoV-2 Vaccine in a University Population in Southern Italy, September to November 2020.

Authors:  Gabriella Di Giuseppe; Concetta Paola Pelullo; Giorgia Della Polla; Maria Pavia; Italo Francesco Angelillo
Journal:  Vaccines (Basel)       Date:  2021-03-18

10.  Gender and AB0 Blood Type Differences in a Unicentric Group of University Professors in Southern Italy Who Received the Vaxzevria COVID-19 Vaccine: A Cross-Sectional Survey of Vaccine Side Effects, Attitudes, and Hesitation.

Authors:  Silvana Mirella Aliberti; Luigi Schiavo; Giovanni Boccia; Emanuela Santoro; Gianluigi Franci; Alessandro Ruggiero; Francesco De Caro; Mario Capunzo
Journal:  Vaccines (Basel)       Date:  2022-02-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.